4,4-dicarboxy-5-pyridoxylproline has been researched along with 4-(4-chlorophenyl)-4-hydroxypiperidine in 1 studies
| Studies (4,4-dicarboxy-5-pyridoxylproline) | Trials (4,4-dicarboxy-5-pyridoxylproline) | Recent Studies (post-2010) (4,4-dicarboxy-5-pyridoxylproline) | Studies (4-(4-chlorophenyl)-4-hydroxypiperidine) | Trials (4-(4-chlorophenyl)-4-hydroxypiperidine) | Recent Studies (post-2010) (4-(4-chlorophenyl)-4-hydroxypiperidine) |
|---|---|---|---|---|---|
| 9 | 0 | 4 | 20 | 0 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capuano, B; Christopoulos, A; Klein Herenbrink, C; Lane, JR; Szabo, M | 1 |
1 other study(ies) available for 4,4-dicarboxy-5-pyridoxylproline and 4-(4-chlorophenyl)-4-hydroxypiperidine
| Article | Year |
|---|---|
Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine Dâ‚‚ receptor.
Topics: Animals; CHO Cells; Cricetulus; Cyclic AMP; Dopamine D2 Receptor Antagonists; Drug Partial Agonism; Ligands; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Piperazines; Piperidines; Radioligand Assay; Receptors, Dopamine D2; Structure-Activity Relationship; Thienopyridines | 2014 |